Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)

NCT00437554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Glimepiride

Sponsor

Handok Inc.